Get the Stockscreener App
0.4305
3.99%
0.0165
Pre-market:
.43
-0.0005
-0.12%
Abpro Holdings Inc stock is traded at $0.4305, with a volume of 8,399.
It is up +3.99% in the last 24 hours and down -29.74% over the past month.
Abpro Holdings Inc is a biotechnology company dedicated to developing next-generation antibody therapeutics with the goal of improving the lives of patients with severe and life-threatening diseases. It is focused on novel antibody constructs for immuno-oncology and ophthalmology. By leveraging its proprietary DiversImmune and MultiMabTM antibody discovery and engineering platforms, The company is developing a pipeline of next-generation antibodies, both independently and through collaborations with global pharmaceutical and research institutions.
See More
Previous Close:
$0.414
Open:
$0.429
24h Volume:
8,399
Relative Volume:
0.06
Market Cap:
$22.37M
Revenue:
-
Net Income/Loss:
$-8.09M
P/E Ratio:
-2.6607
EPS:
-0.1618
Net Cash Flow:
$-8.31M
1W Performance:
-0.35%
1M Performance:
-29.74%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$0.414
$0.445
1-Week Range:
$0.41
$0.4774
52-Week Range:
$0.41
$5.13
Abpro Holdings Inc Stock (ABP) Company Profile
Name
Abpro Holdings Inc
Sector
Industry
Phone
248-890-7200
Address
6 ST JOHNS LANE, FLOOR 5, NEW YORK
Compare ABP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ABP
Abpro Holdings Inc
|
0.4305 | 22.37M | 0 | -8.09M | -8.31M | -0.1618 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.74 | 124.48B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
617.00 | 67.45B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
567.09 | 34.59B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
255.76 | 33.10B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
271.04 | 29.15B | 3.81B | -644.79M | -669.77M | -6.24 |
Abpro Holdings Inc Stock (ABP) Latest News
Abpro Holdings Delays Year-End Financial Report - TipRanks
Abpro Holdings to Present Preclinical Data at AACR 2025 - TipRanks
Abpro Announces Oral Presentation of First Preclinical Data for ABP-102/CT-P72, a Tetravalent Bispecific HER2 x CD3 T-Cell Engager, at AACR Annual Meeting 2025 - TradingView
Groundbreaking Cancer Treatment Data: Abpro's HER2 Therapy Selected for Major AACR Showcase - Stock Titan
Abpro Chief Executive Ian Chan Departs -March 11, 2025 at 04:42 am EDT - Marketscreener.com
Abpro Statement on the Departure of Former CEO Ian Chan - The Manila Times
Abpro Advances Potential Best-in-Class HER2 Cancer Treatment Amid Leadership Change - Stock Titan
3 Stocks Primed for Compounding Wealth This Decade - The Globe and Mail
Why Oil and Gas Giants ExxonMobil, Chevron, and ConocoPhilips Were Down Today on an Up Day for the Market - The Globe and Mail
Reaction to Tariffs Was as Expected - The Globe and Mail
European and U.S. Futures Rise Amid Optimism Over Inflation Data and Tariff Developments - The Globe and Mail
Design Software Stocks Q4 Teardown: Adobe (NASDAQ:ADBE) Vs The Rest - The Globe and Mail
Abpro Holdings Inc Terminates Ian Chan As CEO Effective March 3, 2025 - MarketScreener
Delek Logistics Partners' Q4 Earnings Increase, Revenue Declines -February 25, 2025 at 07:41 am EST - Marketscreener.com
Abpro (NASDAQ:ABP) Now Covered by Analysts at Maxim Group - Defense World
Maxim Group Initiates Coverage of Abpro Holdings (ABP) with Buy Recommendation - Nasdaq
Equitable Holdings Launches $1.8 Billion Tender Offer for AllianceBernstein Units -February 24, 2025 at 06:39 am EST - Marketscreener.com
What To Expect From Myriad Genetics’s (MYGN) Q4 Earnings - The Globe and Mail
Abpro Holdings Highlights Strategic Partnerships in Biotech - TipRanks
Lyft Stock Is an Incredible Buy After Autonomy Push - The Globe and Mail
SolarWinds Shares Rise After Agreeing to Buyout Offer From Turn/River Capital -February 07, 2025 at 11:57 am EST - Marketscreener.com
US Equity Indexes Mixed in Midday Trading -February 06, 2025 at 12:30 pm EST - Marketscreener.com
Alphabet, AMD Earnings Weigh on Investor Sentiment, Driving Premarket Losses for US Equity Futures - Marketscreener.com
S&P 500, Nasdaq rise as megacaps charge ahead; tariffs in focus -February 04, 2025 at 10:37 am EST - Marketscreener.com
Warren Buffett Has $74 Billion of Berkshire Hathaway's $301 Billion Portfolio Tied Up in 2 Leading Artificial Intelligence (AI) Stocks - The Globe and Mail
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Stock market news: Abpro Holdings -52.75%, Traws Pharma -42.47% among biggest losers during mid day trading - Business Upturn
Stock market news: Nxu surged by 276.55% while Abpro Holdings climbed by 136.32% during mid day trading - Business Upturn
Stock market today: Abpro Holdings -42.09%, Traws Pharma -39.26% among biggest losers in early trading - Business Upturn
Vertex Pharmaceuticals (VRTX) Stock Surges Amid Mixed Analyst Ra - GuruFocus.com
Abpro Holdings Celebrates Closing of Business Combination with Nasdaq Bell Ringing - The Manila Times
Abpro Holdings Debuts on Nasdaq with $60M+ Funding Package to Advance Cancer Therapy Pipeline - Stock Titan
Atlantic Coastal Acquisition Corp. II Dismisses Independent Registered Public Accounting Firm - Defense World
Abpro Holdings engages new accounting firm By Investing.com - Investing.com Canada
Abpro Holdings engages new accounting firm - Investing.com
Abpro Holdings Inc Rings the Nasdaq Stock Market Closing Bell - Nasdaq
Abpro Holdings Inc Rings the Closing Bell - Nasdaq
ABP stock touches 52-week low at $2.4 amid market challenges - Investing.com
Abpro Holdings announces CFO departure By Investing.com - Investing.com Canada
Abpro Holdings announces CFO departure - Investing.com
Abpro Holdings announces key post-merger developments - Investing.com
Abpro Holdings announces key post-merger developments By Investing.com - Investing.com Nigeria
Abpro Holdings Inc (ABP) reports earnings - Quartz
Abpro Announces Closing of Business Combination with Atlantic Coastal Acquisition Corp. II - PR Newswire
Abpro Holdings Completes Merger, Starts Nasdaq Trading - TipRanks
Atlantic Coastal Acquisition Corp. II Enters into Forward Purchase Agreement with Abpro Corporation - Defense World
Atlantic Coastal Acquisition Corp. II Corrects Typographical Error in Previous Reports on Business Combination with Abpro - Defense World
Atlantic Coastal Acquisition Corp. II Enters into Non-Redemption Agreement with Abpro Corp On November 5, 2024, Atlantic Coastal Acquisition Corp. II (NASDAQ: ACABU) disclosed in an 8-K filing a significant development regarding its proposed - Defense World
424B3 - SEC.gov
Atlantic Coastal Acquisition Corp. II amends business combination agreement - Investing.com
Atlantic Coastal enters key agreements ahead of merger - Investing.com
Abpro Holdings Inc Stock (ABP) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.89%
0.13%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):